MetaCap

Spero Therapeutics (SPRO) News

NASDAQ: SPROHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.742-0.0843 (-10.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SPRO news summary

We found 6 recent headlines mentioning Spero Therapeutics (SPRO): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. SPRO is making an outsized move today, down 10.20% at $0.742, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 4, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Spero Therapeutics headlines

Stocks mentioned alongside SPRO

Compare SPRO